Five Prime Therapeutics Reports First Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- L3Harris CEO steps down amid conduct review, shares drop
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Five Prime Therapeutics (FPRX) Tops Q1 EPS by 4c
May 8, 2019 4:58 PM EDTFive Prime Therapeutics (NASDAQ: FPRX) reported Q1 EPS of ($1.02), $0.04 better than the analyst estimate of ($1.06). Revenue for the quarter came in at $5.35 million versus the consensus estimate of $4.79 million.
For earnings history and earnings-related data on Five Prime Therapeutics (FPRX) click here.
... More